Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2013

Open Access 01-12-2013 | Research

A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology

Authors: Carlo Alviggi, Kim Pettersson, Salvatore Longobardi, Claus Yding Andersen, Alessandro Conforti, Pasquale De Rosa, Roberto Clarizia, Ida Strina, Antonio Mollo, Giuseppe De Placido, Peter Humaidan

Published in: Reproductive Biology and Endocrinology | Issue 1/2013

Login to get access

Abstract

Background

V-betaLH is a common genetic variant of LH caused by two polymorphic base changes in the beta subunit gene, altering the amino acid sequence (Trp8Arg and Ile15Thr). In a previous-preliminary trial performed in women undergoing IVF, it was demonstrated that carriers of v-betaLH show sub-optimal ovarian response to a standard long GnRH-agonist down -regulation protocol when stimulated with pure recombinant FSH (r-hFSH). The aim of this study was to confirm the hypothesis that women with v-betaLH display hypo-sensitivity to exogenous FSH in a larger IVF population and to explore the frequency of this variant in a Danish female population.

Methods

In the present study, the effect of v-betaLH was retrospectively investigated in a larger series of women undergoing controlled ovarian stimulation (COS) and, for the first time, in a Danish IVF population. A total of 220 normogonadotrophic women following a long GnRH-agonist down-regulation protocol received an individualized dose of r-hFSH (100 IU and 375 IU s.c. daily) according to antral follicle count, baseline FSH, body mass index and age. The LH genotype was assessed in all patients by immunofluorometric assay.

Results

V-betaLH was present in 11% of patients, whereas the allelic frequency was 12%. The study population was divided into two groups according to their LH genotype. Group A consisted of 196 wt/wt women. Group B included 24 individuals with v-betaLH (21 heterozygous and 3 homozygous). No statistically significant differences in the mean number of oocytes retrieved, fertilization rate and pregnancy rate per cycle were observed between groups. However, Group B received a significantly higher cumulative-dose of r-hFSH than Group A (2435.86 +/− 932.8 IU versus 1959.8 +/− 736.45 p = 0.048). When one-way ANOVA in a within design was applied, the LH genotype had a statistically significant effect (p < 0.01) on the cumulative dose of r-hFSH, showing a progressive increase from wt/wt (1959.8 +/− 736.45 IU) to v-betaLH hetero- (2267.5 +/− 824.3) and homozygotic women (3558.3 +/− 970.9).

Conclusions

These results confirm that carriers exhibit hypo-sensitivity to exogenous FSH during COS, documenting that the frequency of v-betaLH in Denmark is similar to a number of European countries.
Appendix
Available only for authorised users
Literature
1.
go back to reference De Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, Colacurci N, Tolino A, Wilding M: Rescue of in vitro fertilisation cycles by human menopausal gonadotropin in pituitary down-regulated normogonadotrophic young women characterised by a poor initial response to recombinant follicle stimulating hormone. Hum Reprod. 2001, 16: 1875-1879. 10.1093/humrep/16.9.1875.CrossRefPubMed De Placido G, Mollo A, Alviggi C, Strina I, Varricchio MT, Ranieri A, Colacurci N, Tolino A, Wilding M: Rescue of in vitro fertilisation cycles by human menopausal gonadotropin in pituitary down-regulated normogonadotrophic young women characterised by a poor initial response to recombinant follicle stimulating hormone. Hum Reprod. 2001, 16: 1875-1879. 10.1093/humrep/16.9.1875.CrossRefPubMed
2.
go back to reference De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, Varricchio MT, Borrelli AL, Conforti S: Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary down regulation. Clin Endocrinol. 2004, 60: 637-643. 10.1111/j.1365-2265.2004.02027.x.CrossRef De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, Varricchio MT, Borrelli AL, Conforti S: Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary down regulation. Clin Endocrinol. 2004, 60: 637-643. 10.1111/j.1365-2265.2004.02027.x.CrossRef
3.
go back to reference Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N: Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 2004, 82: 1521-1526. 10.1016/j.fertnstert.2004.06.041.CrossRefPubMed Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N: Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 2004, 82: 1521-1526. 10.1016/j.fertnstert.2004.06.041.CrossRefPubMed
4.
go back to reference De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A, on behalf of the Italian Collaborative Group on Recombinant Human Luteinizing Hormone: Recombinant human LH supplementation versus recombinant human FSH (r-hFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to r-hFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod. 2005, 20: 390-396.CrossRefPubMed De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A, on behalf of the Italian Collaborative Group on Recombinant Human Luteinizing Hormone: Recombinant human LH supplementation versus recombinant human FSH (r-hFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to r-hFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod. 2005, 20: 390-396.CrossRefPubMed
5.
go back to reference Mochtar MH, van der Veen F, Ziech M, van Wely M: Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2007, 18: CD005070- Mochtar MH, van der Veen F, Ziech M, van Wely M: Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2007, 18: CD005070-
6.
go back to reference Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G: Who needs LH in ovarian stimulation?. Reprod Biomed Online. 2006, 12: 599-607. 10.1016/S1472-6483(10)61186-8.CrossRefPubMed Alviggi C, Clarizia R, Mollo A, Ranieri A, De Placido G: Who needs LH in ovarian stimulation?. Reprod Biomed Online. 2006, 12: 599-607. 10.1016/S1472-6483(10)61186-8.CrossRefPubMed
7.
go back to reference Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G: Suboptimal response to GnRH-a long protocol is associated with a common LH polymorphism. Reprod Biomed Online. 2009, 18: 9-14. 10.1016/S1472-6483(10)60418-X.CrossRefPubMed Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'Uva M, De Placido G: Suboptimal response to GnRH-a long protocol is associated with a common LH polymorphism. Reprod Biomed Online. 2009, 18: 9-14. 10.1016/S1472-6483(10)60418-X.CrossRefPubMed
8.
go back to reference Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C: LH-Receptor Gene Expression in Human Granulosa and Cumulus Cells from Antral and Preovulatory Follicles. J Clin Endocrinol Metab. 2012, 97: 1524-1531. 10.1210/jc.2012-1427.CrossRef Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, Schmidt KT, Ernst E, Yding Andersen C: LH-Receptor Gene Expression in Human Granulosa and Cumulus Cells from Antral and Preovulatory Follicles. J Clin Endocrinol Metab. 2012, 97: 1524-1531. 10.1210/jc.2012-1427.CrossRef
9.
go back to reference Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL: Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med. 1992, 326: 179-183. 10.1056/NEJM199201163260306.CrossRefPubMed Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL: Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med. 1992, 326: 179-183. 10.1056/NEJM199201163260306.CrossRefPubMed
10.
go back to reference Pettersson K, Ding YQ, Huhtaniemi I: An immunologically anomalous luteinizing hormone variant in a healthy woman. J Clin Endocrinolol Metab. 1992, 74: 164-171. 10.1210/jc.74.1.164. Pettersson K, Ding YQ, Huhtaniemi I: An immunologically anomalous luteinizing hormone variant in a healthy woman. J Clin Endocrinolol Metab. 1992, 74: 164-171. 10.1210/jc.74.1.164.
11.
go back to reference Suganuma N, Furui K, Kikkawa F, Tomoda Y, Furuhashi M: Effects of the mutations Trp8™Arg and Ile15™Thr. in human luteinizing hormone LH.beta-subunit on LH bioactivity in vitro and in vivo. Endocrinology. 1996, 137: 831-838. 10.1210/en.137.3.831.PubMed Suganuma N, Furui K, Kikkawa F, Tomoda Y, Furuhashi M: Effects of the mutations Trp8™Arg and Ile15™Thr. in human luteinizing hormone LH.beta-subunit on LH bioactivity in vitro and in vivo. Endocrinology. 1996, 137: 831-838. 10.1210/en.137.3.831.PubMed
12.
go back to reference Haavisto AM, Pettersson K, Bergendahl M, Virkamäki A, Huhtaniemi I: Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab. 1995, 80: 1257-1263. 10.1210/jc.80.4.1257.PubMed Haavisto AM, Pettersson K, Bergendahl M, Virkamäki A, Huhtaniemi I: Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab. 1995, 80: 1257-1263. 10.1210/jc.80.4.1257.PubMed
13.
go back to reference Humaidan P, Bungum L, Bungum M, Andersen CY: Ovarian response and pregnancy outcome related to mid-follicular LH concentrations in women undergoing assisted reproduction with GnRH agonist down regulation and recombinant FSH stimulation. Hum Reprod. 2002, 17: 2016-2021. 10.1093/humrep/17.8.2016.CrossRefPubMed Humaidan P, Bungum L, Bungum M, Andersen CY: Ovarian response and pregnancy outcome related to mid-follicular LH concentrations in women undergoing assisted reproduction with GnRH agonist down regulation and recombinant FSH stimulation. Hum Reprod. 2002, 17: 2016-2021. 10.1093/humrep/17.8.2016.CrossRefPubMed
14.
go back to reference Pettersson K, Söderholm JR: Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. Clin Chem. 1990, 36: 1928-1933.PubMed Pettersson K, Söderholm JR: Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. Clin Chem. 1990, 36: 1928-1933.PubMed
15.
go back to reference Pettersson K, Söderholm JR: Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem. 1991, 37: 333-340.PubMed Pettersson K, Söderholm JR: Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem. 1991, 37: 333-340.PubMed
16.
go back to reference Nilsson C, Jiang M, Pettersson K, Iitiä A, Mäkelä M, Simonsen H, Easteal S, Herrera RJ, Huhtaniemi I: Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxf). 1998, 49: 369-376. 10.1046/j.1365-2265.1998.00532.x.CrossRef Nilsson C, Jiang M, Pettersson K, Iitiä A, Mäkelä M, Simonsen H, Easteal S, Herrera RJ, Huhtaniemi I: Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxf). 1998, 49: 369-376. 10.1046/j.1365-2265.1998.00532.x.CrossRef
17.
go back to reference Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT: Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril. 1997, 67: 998-1004. 10.1016/S0015-0282(97)81430-6.CrossRefPubMed Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT: Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril. 1997, 67: 998-1004. 10.1016/S0015-0282(97)81430-6.CrossRefPubMed
18.
go back to reference Huhtaniemi I, Jiang M, Nilsson C, Pettersson K: Mutations and polymorphisms in gonadotropin genes. Mol Cel Endocrinol. 1999, 151: 89-94. 10.1016/S0303-7207(99)00015-5.CrossRef Huhtaniemi I, Jiang M, Nilsson C, Pettersson K: Mutations and polymorphisms in gonadotropin genes. Mol Cel Endocrinol. 1999, 151: 89-94. 10.1016/S0303-7207(99)00015-5.CrossRef
19.
go back to reference Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I, Clayton RN: Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1995, 43: 297-303. 10.1111/j.1365-2265.1995.tb02035.x.CrossRef Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I, Clayton RN: Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1995, 43: 297-303. 10.1111/j.1365-2265.1995.tb02035.x.CrossRef
20.
go back to reference Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS, Huhtaniemi I: A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. J Clin Endocrinol Metab. 1999, 84: 1711-1715. 10.1210/jc.84.5.1711.PubMed Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS, Huhtaniemi I: A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. J Clin Endocrinol Metab. 1999, 84: 1711-1715. 10.1210/jc.84.5.1711.PubMed
21.
go back to reference Takahashi K, Kurioka H, Ozaki T, Kanasaki H, Kohsaka M, Miyazaki K, Karino K: Increased prevalence of luteinizing hormone beta-subunit variant in Japanese infertility patients. Hum Reprod. 1998, 13: 3338-3344. 10.1093/humrep/13.12.3338.CrossRefPubMed Takahashi K, Kurioka H, Ozaki T, Kanasaki H, Kohsaka M, Miyazaki K, Karino K: Increased prevalence of luteinizing hormone beta-subunit variant in Japanese infertility patients. Hum Reprod. 1998, 13: 3338-3344. 10.1093/humrep/13.12.3338.CrossRefPubMed
22.
go back to reference Takahashi K, Karino K, Kanasaki H, Miyazaki K: Altereted kinetics of pituitary response to gonadotropin-release hormone in woman with variant luteinizing hormone: correlation with ovulatory disorders. Horm Res. 2004, 61: 27-32. 10.1159/000075194.CrossRefPubMed Takahashi K, Karino K, Kanasaki H, Miyazaki K: Altereted kinetics of pituitary response to gonadotropin-release hormone in woman with variant luteinizing hormone: correlation with ovulatory disorders. Horm Res. 2004, 61: 27-32. 10.1159/000075194.CrossRefPubMed
23.
go back to reference Chen X, Zhou B, Yan J, Xu B, Tai P, Li J, Peng S, Zhang M, Xia G: Epidermal growth factor receptor activation by protein kinase C is necessary for FSH-induced meiotic resumption in porcine cumulus-oocyte complexes. J Endocrinol. 2008, 197: 409-419. 10.1677/JOE-07-0592.CrossRefPubMed Chen X, Zhou B, Yan J, Xu B, Tai P, Li J, Peng S, Zhang M, Xia G: Epidermal growth factor receptor activation by protein kinase C is necessary for FSH-induced meiotic resumption in porcine cumulus-oocyte complexes. J Endocrinol. 2008, 197: 409-419. 10.1677/JOE-07-0592.CrossRefPubMed
24.
go back to reference Wang C, Xu B, Zhou B, Zhang C, Yang J, Ouyang H, Ning G, Zhang M, Shen J, Xia G: Reducing CYP51 inhibits follicle-stimulating hormone induced resumption of mouse oocyte meiosis in vitro. J Lipid Res. 2009, 50: 2164-2172. 10.1194/jlr.M800533-JLR200.PubMedCentralCrossRefPubMed Wang C, Xu B, Zhou B, Zhang C, Yang J, Ouyang H, Ning G, Zhang M, Shen J, Xia G: Reducing CYP51 inhibits follicle-stimulating hormone induced resumption of mouse oocyte meiosis in vitro. J Lipid Res. 2009, 50: 2164-2172. 10.1194/jlr.M800533-JLR200.PubMedCentralCrossRefPubMed
25.
go back to reference Yang J, Fu M, Wang S, Chen X, Ning G, Xu B, Ma Y, Zhang M, Xia G: An Antisense Oligodeoxynucleotide to the LH Receptor Attenuates FSH-induced Oocyte Maturation in Mice. Asian-Aust J Anim Sci. 2008, 21: 972-979.CrossRef Yang J, Fu M, Wang S, Chen X, Ning G, Xu B, Ma Y, Zhang M, Xia G: An Antisense Oligodeoxynucleotide to the LH Receptor Attenuates FSH-induced Oocyte Maturation in Mice. Asian-Aust J Anim Sci. 2008, 21: 972-979.CrossRef
26.
go back to reference Humaidan P, Bungum M, Bungum L, Yding Andersen C: Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online. 2004, 8: 635-643. 10.1016/S1472-6483(10)61643-4.CrossRefPubMed Humaidan P, Bungum M, Bungum L, Yding Andersen C: Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online. 2004, 8: 635-643. 10.1016/S1472-6483(10)61643-4.CrossRefPubMed
27.
go back to reference Smyth CD, Miró F, Whitelaw PF, Howles CM, Hillier SG: Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology. 1993, 133: 1532-1538. 10.1210/en.133.4.1532.PubMed Smyth CD, Miró F, Whitelaw PF, Howles CM, Hillier SG: Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology. 1993, 133: 1532-1538. 10.1210/en.133.4.1532.PubMed
Metadata
Title
A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology
Authors
Carlo Alviggi
Kim Pettersson
Salvatore Longobardi
Claus Yding Andersen
Alessandro Conforti
Pasquale De Rosa
Roberto Clarizia
Ida Strina
Antonio Mollo
Giuseppe De Placido
Peter Humaidan
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2013
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-11-51

Other articles of this Issue 1/2013

Reproductive Biology and Endocrinology 1/2013 Go to the issue